Provided by Tiger Trade Technology Pte. Ltd.

Avalo Therapeutics Inc

18.95
-0.3900-2.02%
Pre-market: 18.83-0.1200-0.63%06:21 EDT
Volume:606.64K
Turnover:11.61M
Market Cap:1.02B
PE:-4.30
High:19.70
Open:19.19
Low:18.85
Close:19.34
52wk High:24.27
52wk Low:8.65
Shares:53.63M
Float Shares:40.15M
Volume Ratio:0.69
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4100
EPS(LYR):-5.8400
ROE:-36.27%
ROA:-18.50%
PB:2.27
PE(LYR):-3.24

Loading ...

Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes

THOMSON REUTERS
·
Jun 26

Avalo Therapeutics CMO Mittie Doyle Disposes of 1,450 Common Shares Valued at $26,100

Reuters
·
Jun 26

Avalo Therapeutics Director Philip Ron M Files Initial Beneficial Ownership Statement

Reuters
·
Jun 26

Avalo Therapeutics appoints Ron Philip to board of directors

Reuters
·
Jun 23

Avalo Therapeutics Appoints Ron Philip to Board of Directors

THOMSON REUTERS
·
Jun 23

Avalo Therapeutics posts corporate deck highlighting IL-1β pipeline in hidradenitis suppurativa

Reuters
·
Jun 16

Avalo Therapeutics - to Submit Ind Application for Avtx-10 in First Half of 2027

THOMSON REUTERS
·
Jun 16

Avalo Therapeutics Expands Pipeline With Avtx-010, a Long-Acting Next-Generation Anti-Il-1Β Antibody

THOMSON REUTERS
·
Jun 16

Avalo Therapeutics targets 1H 2027 IND for long-acting anti-IL-1β antibody AVTX-010

Reuters
·
Jun 16

Kratos, AMD, CCEP, Avalo, WSM Trending With Analysts

TIPRANKS
·
Jun 13

Avalo Therapeutics amends executive employment deals, boosts change-in-control severance terms

Reuters
·
Jun 13

Avalo Therapeutics' Lead Drug now a Cleaner Immunology Story, BofA Says

MT Newswires Live
·
Jun 12

Avalo Therapeutics : Bofa Global Research Initiates Coverage With Buy Rating and Price Objective $35.00

THOMSON REUTERS
·
Jun 12

Avalo Therapeutics initiated with a Buy at BofA

TIPRANKS
·
Jun 12

U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle

Reuters
·
Jun 12

Avalo Therapeutics shareholders approved amended employee stock purchase plan at annual meeting

Reuters
·
Jun 09

Avalo Therapeutics CMO Mittie Doyle disposes of 679 common shares for $10,864

Reuters
·
Jun 02

Avalo Therapeutics grants new hire option for 34,000 shares at $16.6 each

Reuters
·
May 23

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 23

Avalo CMO Mittie Doyle disposes 3,000 shares for $56,280

Reuters
·
May 20